Back to mobile site

Sunesis Pharmaceuticals Inc. (SNSS) PT Lowered to $3 at Cantor Fitzgerald Following MAA Withdrawl

May 2, 2017 6:53 AM EDT Send to a Friend
Cantor Fitzgerald lowered its price target on Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) to $3.00 (from $5.00) while maintaining a Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login